AUXL: To Present At Lazard Capital Healthcare Conference @ 13:00 ET [delayed] -
Auxilium Pharmaceuticals to Present at the Piper Jaffray 20th Annual Healthcare Conference -
Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference -
AUXL: To Present At Oppenheimer Healthcare Conference @ 11:20 ET [delayed] -
Market Review: Our Progressive Review of AUXL -
AUXILIUM PHARMA REUTERS ESTIMATES Q3 SHR VIEW $-0.28, REV VIEW $32.55 MLN -
AUXILIUM PHARMACEUTICALS INC Q3 REVENUE $32.6 MLN VS $26.2 MLN -
AUXILIUM PHARMACEUTICALS INC Q3 SHR LOSS $0.24 -
Auxilium Pharmaceuticals Finished Monday at Second Consecutive New Low for Year -
Auxilium Pharmaceuticals Finishes At Lowest Level In Over A Year -
Auxilium Pharmaceuticals Closes At Yearly Low -
AUXL: To Present At UBS Global Life Sciences Conference @ 10:30 ET [delayed] -
Auxilium initiates dosing for Phase IIb Peyronie's trial -
Auxilium Pharmaceuticals to Present at the 2008 UBS Global Life Sciences Conference -
BSTC: Initiation of Phase IIb Trial for Peyronie's Disease -
BSTC: Buys Down Future Royalties for XIAFLEX(TM) in Peyronie's Disease -
BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease -